All In MedTech

FDA Clearance Tracker · K200065

cobas Influenza A/B Nucleic acid test for use on the cobas Liat System, cobas Influenza A/B & RSV Nucleic acid test for use on the cobas Liat System, cobas Strep A Nucleic acid test for use on the cobas Liat System

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: Feb 10, 2020 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Feb 10, 2020

Substantially Equivalent

Time to decision

28 days

Received Jan 13, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Special

Device class

Class II

The decision

FDA number
K200065
Device name
cobas Influenza A/B Nucleic acid test for use on the cobas Liat System, cobas Influenza A/B & RSV Nucleic acid test for use on the cobas Liat System, cobas Strep A Nucleic acid test for use on the cobas Liat System
Applicant location
Pleasanton, CA
Received
Jan 13, 2020
Decided
Feb 10, 2020
Decision
Substantially Equivalent
Submission type
Special

Device type

Device class
Class II
Regulation
21 CFR 866.3980

Every decision under product code OCC

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code OCC. The earliest in FDA's data is DEN070013, decided Jan 3, 2008.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Roche Molecular Systems, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.